AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression

Bibliographic Details
Title: AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression
Authors: Peng Ma, Ying Hao, Wei Wang, Yue-Feng Zhang, Kai-Huan Yu, Wei-Xing Wang
Source: Discover Oncology, Vol 14, Iss 1, Pp 1-12 (2023)
Publisher Information: Springer, 2023.
Publication Year: 2023
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Intrahepatic cholangiocarcinoma (ICC) is a fatal disease and the molecular mechanism of its progression remains unknown. Aurora Kinase B (AURKB) is a central regulator of chromosome separation and cytokinesis and is abnormally expressed in a variety of cancer cells. This research aimed to explore the effect of AURKB in occurrence and metastasis of ICC. We found that AURKB showed a progressive up-regulation pattern from normal bile duct tissue to ICC with high invasion. Our data showed that AURKB significantly promoted ICC cell proliferation, induced epithelial-mesenchymal transition (EMT), migration and invasion through gain- and loss- of function experiments. In vivo results consistently showed that AURKB up-regulation not only promoted tumor growth, but also promoted tumor metastasis. Importantly, we discovered that AURKB regulates the expressions of EMT-related genes via PI3K/AKT signaling axis. Herein, our results suggest that AURKB induced EMT through the activation of PI3K/AKT signaling pathway is critical to the progression of ICC, which may be a prospective therapeutic treatment for overcoming ICC metastasis and progression.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2730-6011
Relation: https://doaj.org/toc/2730-6011
DOI: 10.1007/s12672-023-00707-1
Access URL: https://doaj.org/article/03c69d46933a4ad08fbbb876698f7633
Accession Number: edsdoj.03c69d46933a4ad08fbbb876698f7633
Database: Directory of Open Access Journals
More Details
ISSN:27306011
DOI:10.1007/s12672-023-00707-1
Published in:Discover Oncology
Language:English